"Density Lowering Effect of OFS Add on to TMX(DELFINO Trial)"

PHASE3RecruitingINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

September 3, 2018

Primary Completion Date

December 2, 2024

Study Completion Date

December 31, 2024

Conditions

Breast Cancer Invasive

Interventions

DRUG

Leuplin or zoladex

OFS(Leuplin or zoladex) add on to TMX

Trial Locations (1)

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT03664895 - "Density Lowering Effect of OFS Add on to TMX(DELFINO Trial)" | Biotech Hunter | Biotech Hunter